Secondary immunodeficiency after B-cell depletion: Mechanisms, clinical manifestations, monitoring, and management
Authors:
- Márcia Toraiwa IwashitaMIMárcia Toraiwa Iwashita
- Ludmilla MasieroLMLudmilla Masiero
- Patrícia FaddulPFPatrícia Faddul
- Isabella FariaIFIsabella Faria
- Guilherme BurgarelliGBGuilherme Burgarelli
- Aline Maria QueirozAline Maria Queiroz
- Estrela GianiEGEstrela Giani
- Giovanna Kyoopee Takahashi Ferreira CostaGCGiovanna Kyoopee Takahashi Ferreira Costa
- Samar Freschi BarrosSBSamar Freschi Barros
- Maria Lúcia Carnevalle MarinMMMaria Lúcia Carnevalle Marin
- Amanda MelatoAMAmanda Melato
- Flávia Pileggi GonçalvesFGFlávia Pileggi Gonçalves
Open Access
- 5 June 2026
- journal article
- Published by Elsevier in Clinical Immunology Communications
- Vol. 10, 100133
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Prophylactic Immunoglobulin Supplementation for Infection Prevention in Multiple Myeloma: An Updated Systematic Review and Meta-AnalysisClinical Lymphoma Myeloma and Leukemia, 2026
- If and When to Consider Prophylactic Immunoglobulin Replacement Therapy in Secondary HypogammaglobulinemiaThe Journal of Allergy and Clinical Immunology: In Practice, 2024
- Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortalityJournal of Allergy and Clinical Immunology, 2024
- Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximabAnnals of Allergy, Asthma & Immunology, 2023
- Infection risk in a real-world cohort of patients treated with long-term B-cell depletion for autoimmune neurologic diseaseMultiple Sclerosis and Related Disorders, 2022
- Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response CommitteesJournal of Allergy and Clinical Immunology, 2022
- Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future DirectionsThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patientsJournal of Allergy and Clinical Immunology, 2021
- B cell targeted therapies in autoimmune diseaseCurrent Opinion in Immunology, 2019
- Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and HypogammaglobulinemiaJAMA Network Open, 2018